|
Allergy Therapeutics PLC - Company Profile Snapshot
| Company Profile: |
Allergy Therapeutics PLC |
| Ticker: |
AGY |
| Exchanges: |
OTC |
| 2009 Sales: |
37,757,000 |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Ethical Drug Manufacturers |
| Country: |
UNITED KINGDOM |
| Employees: |
374 |
Business Description
Allergy Therapeutics PLC. The Group's principal activity is developing, manufacturing, marketing and selling a range of pharmaceutical vaccine products designed for the immunological treatment of the allergic condition. Vaccinations take the form of allergen-specific, named-patient-specific and standard products in injectable and sublingual presentations. The Group's allergy vaccination focuses on advance of progressive allergic conditions that can often culminate in severe, life-threatening asthma. Product brands are Pollinex Quattro and Oralvac Plus. The Group's product focuses on Ultra-short-course vaccines for allergy to major pollens and sublingual vaccines for allergy to major pollens, house dust mite and cat.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
